Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Previous studies reported suppressive effects of antiplatelet agents on hepatocellular carcinoma (HCC); however, this has never been assessed in patients who underwent liver transplantation (LT). This retrospective observational study used data from LT recipients with pre-transplant HCC in a single...

Full description

Bibliographic Details
Main Authors: Mun Chae Choi, Eun-Ki Min, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim, Deok-Gie Kim
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
liver transplantation
antiplatelet
hepatocellular carcinoma
thromboprophylaxis
Online Access:https://www.mdpi.com/2072-6694/14/21/5329

Internet

https://www.mdpi.com/2072-6694/14/21/5329

Similar Items